Saba Capital Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.7M Buy
1,348,202
+588,696
+78% +$8.47M 0.53% 42
2026
Q1
$10.9M Buy
+759,506
New +$11.3M 0.3% 69
2025
Q2
Sell
-20,750,913
Closed -$309M 328
2025
Q1
$309M Hold
20,750,913
8.36% 3
2024
Q4
$299M Buy
20,750,913
+89,523
+0.4% +$1.39M 7% 3
2024
Q3
$327M Buy
20,661,390
+122,959
+0.6% +$1.94M 6.82% 3
2024
Q2
$315M Buy
20,538,431
+46,421
+0.2% +$704K 5.25% 4
2024
Q1
$336M Buy
20,492,010
+3,705,172
+22% +$58.4M 5.75% 4
2023
Q4
$246M Buy
16,786,838
+8,439,174
+101% +$118M 4.95% 3
2023
Q3
$120M Buy
8,347,664
+1,827,094
+28% +$28.5M 2.89% 8
2023
Q2
$107M Buy
6,520,570
+2,043,886
+46% +$33.3M 2.79% 6
2023
Q1
$74.8M Buy
4,476,684
+2,008,373
+81% +$32.3M 1.43% 8
2022
Q4
$38.1M Buy
+2,468,311
New +$38.2M 0.52% 20

Other funds holding BMEZ

Saba Capital Management's BMEZ Position: Q2 2026 in Review

Saba Capital Management increased its BlackRock Health Sciences Trust II (BMEZ) stake by 78% in Q2 2026, buying an estimated $8.47M and bringing the position to 1,348,202 shares worth $20.7M. The position accounts for 0.53% of the portfolio, ranked #42.

Saba Capital Management first reported a position in BMEZ in Q4 2022 and has held it in 12 quarters since. The position peaked at $336M in Q1 2024. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Saba Capital Management held 1,348,202 shares of BlackRock Health Sciences Trust II worth $20.7M as of Q2 2026.
  • Saba Capital Management bought 588,696 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $8.47M.
  • BlackRock Health Sciences Trust II made up 0.53% of Saba Capital Management's portfolio in Q2 2026, its #42 holding.
  • Saba Capital Management first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and has held it in 12 quarters since.
  • Saba Capital Management's BlackRock Health Sciences Trust II position peaked at $336M in Q1 2024.
  • 89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Saba Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.